Trial reportOpen heart2026
Prognostic value of baseline and longitudinal changes in exercise capacity and quality of life in the HF-Wii Swedish population.
Trial report in Open heart, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01785121 (Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming (HF-Wii) A Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to explore whether baseline values and 12-month change in the 6-Minute Walk Distance (6MWD) and the physical scale of the Minnesota Living with Heart Failure Questionnaire (MLHFQ) were associated with long-term mortality in patients with heart failure (HF).
methodsA total of 333 patients with HF, enrolled in the HF-Wii trial (NCT01785121) in Sweden, were included. Data on long-term mortality were gathered 3 years after study completion of the last patient included. Study participants were stratified into three groups based on baseline results of the 6MWD: group 1: ≤383 m, group 2: 384-450 m and group 3: ≥451 m. Similarly, tertiles were formed according to baseline MLHFQ physical domain scores: group 1: 0-5 points, group 2: 6-12 points and group 3: 13-40 points.
resultsDuring a median (25th-75th percentiles) follow-up of 1900 (1566, 2271) days, 48 patients died (14.4%). Patients in group 1 of 6MWD displayed a more severe clinical status in comparison to patients in groups 2 and 3. Kaplan-Meier survival analysis showed a statistically significant between-group difference in survival, observed per tertile groups of the baseline 6MWD. However, no significant difference in survival was found in relation to changes in 6MWD over time. Likewise, there were not statistically significant between-group differences in survival per tertile groups of the baseline score on the physical domain of MLHFQ nor with respect to change over time of the same score.
conclusionsBaseline 6MWD demonstrated significant prognostic value for long-term mortality in patients with HF whereas the physical score of MLHFQ, as well as their 12-month changes did not reach statistical significance. TRIAL REGISTRATION NUMBER: NCT01785121.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.